Table of Contents Table of Contents
Previous Page  75 / 464 Next Page
Information
Show Menu
Previous Page 75 / 464 Next Page
Page Background

SATURDAY 6 MAY 2017

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

75

Programme and Exhibition Guide |

SCIENTIFIC PROGRAMME

JOINT SYMPOSIUM

ESTRO-AAPM: New technological and computational developments in

particle therapy

08:45 - 10:00 | STRAUS 2-3

The session will focus on three aspects:

The role of ‘compact solutions’ in proton therapy. We’ll review what is available, see

an example of how a centre did fit its department to the new needs, what it takes to

‘shrink’ these facilities further to fit in a conventional bunker and whether a fixed line

may still be adequate.

Concerning imaging, we’ll discuss the role of Cone beam CT(CBCT), i.e. design

of different CBCT systems, their use for different treatment sites, its quantitative

applications, the limitations of different methods for using CBCT for dose calculation,

and the use of CBCT in an adaptive ion therapy.

On treatment planning, we’ll outline the limitations of compensating systematic and

random uncertainties by dose planning, argue whether probabilistic planning can

achieve risk minimisation of geometric uncertainties via direct consideration in dose

optimisation and finally we’ll bring up the issue of the uncertainties associated with

estimating uncertainties.

Chair: M. Schwarz (Italy)

Co-chair: T. Bortfeld (USA)

08:45 > Scaling down proton therapy facilities to fit into photon vaults

Speaker: T. Bortfeld (USA)

SP-0019

09:10 > Integrating CBCT in ion beam therapy: challenges and opportunities

beyond anatomical guidance

Speaker: K. Teo (USA)

SP-0020

09:35 > New horizons in probabilistic and robust treatment planning in particle

therapy

Speaker: M. Alber (Germany)

SP-0021

SYMPOSIUM

CT imaging, new developments

08:45 - 10:00 | LEHAR 1-3

Modern radiotherapy relies heavily on pre-treatment imaging, both to determine

the target volumes, delineate organs at risk and to build an attenuation model of the

patient to facilitate accurate dose calculations. Magnetic resonance and positron